About Us
Company Overview
Amar Biosystems is dedicated to advancing microfluidic and microreactor-based technologies for the life science industry. Our solutions support advancements in nanoparticles, mRNA vaccines, and nucleic acid-based therapeutics for infectious diseases, cancer, and rare conditions. Founded in February 2024 and inspired by research at the Institute of Chemical Technology, Mumbai, we focus on bridging the gap between research and large-scale production.
By delivering scalable, high-quality, and regulatory-compliant manufacturing solutions, we aim to drive innovation in precision medicine and biopharmaceuticals, enabling faster and more cost-effective drug development.
To revolutionize nanomedicine manufacturing by developing cost-effective, scalable, and domestically produced microfluidic platforms and raw materials, enabling widespread access to next-generation therapeutics.
At Amar Biosystems, we are committed to transforming lipid nanoparticle synthesis through advanced, GMP-compliant microfluidic platforms that enhance efficiency, consistency, and affordability. By localizing the production of cutting-edge manufacturing systems and critical raw materials, we aim to reduce dependency on imports, lower therapy costs, and drive innovation in vaccines, cell and gene therapies, and precision medicine. Through technological excellence and strategic partnerships, we empower the pharmaceutical and biotech industries with sustainable, high-quality solutions that improve global healthcare accessibility.
Leadership Team
Mr. Vishal Shah
Founder and Director
Dr. Ratnesh Jain
Strategic Advisor
Core Team
Dr. Ganesh Gaikwad
Head, Product Development
Ms. Keerthi Renganathan
Research Scientist,
Formulation Development
Mr. Asrar Maqbool
Business Development Assistant
Mr. Aditya Lakhe
Junior Embedded
Systems Engineer